In short
Menotrophin, also known as human menopausal gonadotropin (hMG), is a medication used in the treatment of infertility. This article explores recent clinical trials investigating the efficacy and safety of Menotrophin, particularly its use in controlled ovarian stimulation for assisted reproductive technologies like in vitro fertilization (IVF). The trials compare Menotrophin to other fertility medications and examine its effects on pregnancy rates, oocyte retrieval, and overall treatment outcomes.
At a glance
- Primary Use
- Controlled ovarian stimulation for IVF and other assisted reproductive technologies
- Administration
- Daily subcutaneous injections, typically 150-300 IU based on patient factors
- Key Outcomes Measured
- Number of oocytes retrieved, pregnancy rates, embryo quality, ongoing pregnancy rates
- Comparisons
- Often compared to recombinant FSH and other gonadotropins for efficacy
- Safety Monitoring
- Trials monitor for adverse events, including ovarian hyperstimulation syndrome
- Additional Assessments
- Follicular development, hormone levels, fertilization rates
What is Menotrophin?
Menotrophin, also known as human menopausal gonadotropin (hMG), is a medication used in fertility treatments. It's commonly marketed under brand names such as Menopur®, IVF-M HP, and MENOPUR® Multidose. This drug is a highly purified form of hormones extracted from the urine of postmenopausal women.
How Does Menotrophin Work?
Menotrophin contains two important hormones: follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These hormones work together to stimulate the ovaries to produce eggs. In fertility treatments, menotrophin is used to help women develop multiple eggs, which can then be retrieved for procedures like in vitro fertilization (IVF).
Conditions Treated with Menotrophin
Menotrophin is primarily used to treat infertility in women. It's particularly helpful in the following situations:
- Women undergoing IVF or other assisted reproductive technologies (ART)
- Women with ovulation disorders who are not responding to other treatments
- Couples with unexplained infertility
How is Menotrophin Administered?
Menotrophin is typically administered through subcutaneous injections (injections just under the skin). The treatment usually follows these steps:
- Starting dose: Usually 150-225 IU daily, often beginning on day 2 or 3 of the menstrual cycle
- Duration: The treatment can last up to 20 days, depending on the individual's response
- Monitoring: Regular ultrasounds and blood tests are performed to track the development of follicles (structures in the ovaries that contain eggs)
- Dose adjustment: The dose may be adjusted based on the individual's response
- Triggering ovulation: Once the follicles reach a certain size, another hormone (human chorionic gonadotropin or hCG) is given to trigger final egg maturation
Effectiveness of Menotrophin
The effectiveness of menotrophin has been studied in several clinical trials. Key findings include:
- Ongoing pregnancy rates: Studies have shown ongoing pregnancy rates of around 30-40% in women treated with menotrophin
- Number of eggs retrieved: On average, women treated with menotrophin produce 8-10 eggs per cycle
- Fertilization rates: About 60-70% of mature eggs retrieved after menotrophin treatment are successfully fertilized
Potential Side Effects
While menotrophin is generally well-tolerated, it can cause some side effects. These may include:
- Ovarian hyperstimulation syndrome (OHSS): A condition where the ovaries become swollen and painful
- Multiple pregnancies: There's an increased risk of twins or triplets
- Injection site reactions: Redness, pain, or swelling at the injection site
- Hormonal symptoms: Mood swings, breast tenderness, or bloating
Comparison with Other Fertility Treatments
Menotrophin is often compared to other fertility medications, particularly recombinant FSH (rFSH). Studies have shown that:
- Menotrophin and rFSH have similar effectiveness in terms of pregnancy rates
- Some studies suggest that menotrophin may result in slightly higher live birth rates compared to rFSH
- The choice between menotrophin and rFSH often depends on individual patient factors and doctor preferences